MPM
CLBT icon

Meritage Portfolio Management’s Cellebrite CLBT Stock Holding History

Meritage Portfolio Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$686K Sell
38,060
-4,613
-11% -$82.8K 0.05% 201
2025
Q3 		$791K Sell
42,673
-19,603
-31% -$308K 0.05% 195
2025
Q2 		$996K Buy
62,276
+1,717
+3% +$30.6K 0.06% 191
2025
Q1 		$1.18M Buy
60,559
+30,658
+103% +$645K 0.08% 183
2024
Q4 		$659K Buy
29,901
+2,070
+7% +$39.8K 0.04% 227
2024
Q3 		$469K Buy
27,831
+2,973
+12% +$44.1K 0.03% 261
2024
Q2 		$297K Buy
24,858
+287
+1% +$3.21K 0.02% 298
2024
Q1 		$272K Buy
+24,571
New +$251K 0.02% 306

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Meritage Portfolio Management's CLBT Position: Q4 2025 in Review

Meritage Portfolio Management reduced its Cellebrite (CLBT) stake by 11% in Q4 2025, selling an estimated $82.8K and leaving 38,060 shares worth $686K. The position accounts for 0.05% of the portfolio, ranked #201.

Meritage Portfolio Management first reported a position in CLBT in Q1 2024 and has held it in 8 quarters since. The position peaked at $1.18M in Q1 2025. 209 funds tracked by Wall St. Rank hold CLBT as of Q4 2025.

  • Meritage Portfolio Management held 38,060 shares of Cellebrite worth $686K as of Q4 2025.
  • Meritage Portfolio Management sold 4,613 Cellebrite shares in Q4 2025, an estimated $82.8K.
  • Cellebrite made up 0.05% of Meritage Portfolio Management's portfolio in Q4 2025, its #201 holding.
  • Meritage Portfolio Management first reported a position in Cellebrite in Q1 2024 and has held it in 8 quarters since.
  • Meritage Portfolio Management's Cellebrite position peaked at $1.18M in Q1 2025.
  • 209 funds tracked by Wall St. Rank held Cellebrite as of Q4 2025.

Based on Meritage Portfolio Management's 13F filing for Q4 2025, filed 27 Jan 2026.